Human Data Can’t Wait for Clinical Trials.
3D HUMAN BIOLOGY-ON-A-CHIP FOR Humanized Drug Discovery and Diagnostic Applications
Accelerating drug discovery with AIM Biotech’s humanized BioAvatar products & services.
From the most demanding basic research, to predictive screens for drug discovery, to the tailored selection of precision medicines, AIM Biotech enables and accelerates the development of cutting-edge therapeutics. This is made possible through AIM Biotech’s BioAvatar technology, which embodies our core expertise in the design and manufacture of sophisticated microfluidic systems and human tissue models. Our BioAvatars combine unmatched recapitulation of human biology with unparalleled ease-of-use, resulting in a powerful solution to move medicine forward.
BioAvatars enable:
Humanized pre-clinical insights for increased predictability of clinical outcomes
Acceleration of the drug discovery process through easy-to-implement humanized organ-on-a-chip models
Replacement of animal models in pre-clinical trials
Introducing our idenTx Family
Introducing idenTx: the humanized 3D tissue culture platform for drug discovery
Easy-to-use. Flexible. Scalable. AIM Biotech’s idenTx line of 3D tissue culture chips and plates enable predictive human BioAvatars that more recapitulate human microphysiology more accurately than traditional cell culture or animal models. Available in formats for 3, 9, and 40 parallel experiments, idenTx multiplies your throughput in alignment with your drug discovery programs.
All with no special equipment and in conjunction with your existing laboratory workflow and automation. With the new idenTx platform, AIM Biotech has taken our proven AIM chips and plates to the next level of scalability and refinement, enabling human-focused, clinically-relevant results that accelerate the development of cutting-edge therapies.
Human biology-on-a-chip. Simplified.
idenTx 3 Chip
AIM Biotech’s proven 3D Cell Culture Chip, DAX-1
This is AIM Biotech’s proven 3D Cell Culture Chip, now part of the idenTx family. Designed in a microscope slide format, this most basic component of the idenTx family enables 3 simultaneous experiments. It is ideal for establishing experimental feasibility or for general low-throughput applications.
Human biology-on-a-chip. Standardized.
idenTx 9 Plate
Three fully integrated idenTx 3 Chips enable 9 simultaneous experiments; scale up for introduction of plate-based robotics and automation.
Human biology-on-a-chip. Multiplied.
idenTx 40 Plate
Highest-throughput plate option, enabling 40 simultaneous experiments to fully accelerate drug discovery through high-content screening.
Human Data. Experimental Simplicity.
Scalability without Compromise.
Unmatched ease-of-use: no special handling, no special training, no special hardware
Built in Scalability to take your research from feasibility to higher throughput screening
Your study. Our lab. Human data.
Contract research services for humanized, organ-on-a-chip studies
With AIM Biotech contract research services, increasing throughput while maintaining assay sophistication is our expertise. Our pharma-focused solutions combine speed and simplicity with the ability to model complex tissues that you expect from organ-on-a-chip assays.
Let AIM Biotech accelerate your drug discovery programs using our humanized BioAvatar Technology in our state-of-the-art research services lab. Our team can even work with you to design, develop, and execute custom assays to deliver human-focused, clinically-relevant results that move your drug discovery programs forward.
Custom assay development
Rapid humanized throughput
Functional immuno-oncology assays
Answer primary research questions
Data on routine screens
In-vitro organ models
Run simple assays or create complex biological models
Your path to predictive data and insightful diagnostics.
Products
Simple-to-use, fully scalable microfluidic systems in plate and chip formats to recapitulate human physiology.
Assays
Validated protocols in T-cell efficiency, immunotherapies, cell migration, vasculogenesis and more
Services
Custom assay development and higher-throughput, high-content screening with assays of your choice
Research
Feasibility studies
Drug/target ID
Mechanism of action
Assay development
Drug Discovery
In vitro screening
Lead optimization
ADME toxicity studies
Safety pharmacology
Diagnostics
Biomarkers
Cohort selection
Personal/targeted Tx
Clinical avatar
The AIM Biotech product family is getting multiplied
AIM’s 3D cell culture technology has always been about empowering preclinical research with better data and more predictive, humanized models. Powered by technology developed in the research labs of Dr. Roger Kamm at the Massachusetts Institute of Technology, the flexibility of our models to...
Building a functional human vascular disease model using AIM Biotech 3D cell culture technology
Understanding the interactions between endothelial cells and vascular smooth muscle cells is critical for the study of vascular disease. Yet, there are few existing models which can simply and reliably recapitulate the cellular crosstalk in human microvascular networks. However, in a recent...
Immunotherapy month: T-cells and transplants—avoiding cancer relapse after liver transplantation using AIM Biotech’s organ-on-a-chip assays
To round out our month-long series highlighting research on adoptive T cell immunotherapy, today we’ll take a look at how scientists are modifying T cells to help prevent cancer relapse on liver transplanted patients, harnessing AIM Biotech’s technology. In cases where a liver tumor can’t be...